Welcome and OverviewScott Lippman, MD Moores Cancer CenterApril 11, 2013Speakers: Scott Lippman, MD, /search?speakers= Run Time: 21 minutes Scott Lippman, MD, is a professor of medicine at UC San Diego and holds the Chugai Pharmaceutical Chair in Cancer. He has participated in the... |
From bench to FDA approval at the Moores Cancer CenterAnne Wallace, MD, Moores Cancer CenterApril 11, 2013Speakers: Anne Wallace Run Time: 18 minutes Anne Wallace, MD, is the Chief of the Division of Plastic, concurrently with her role as Team Leader of the Moores Cancer Center's breast program.... |
Part II: The Mouse That ROR’ed – Targeting Onco-Embryonic AntigensThomas Kipps, MD, PhD, Moores Cancer CenterApril 11, 2013Speakers: Thomas Kipps Run Time: 19 minutes Thomas Kipps, MD, PhD, is Professor of Medicine, Evelyn and Edwin Tasch Chair in Cancer Research, and Interim Director of the Moores Cancer Center. A... |
Translational Oncology activity of Kyowa Kirin, Discovery and development of CCR4 monoclonal antibody, mogamulizumabYukimasa Shiotsu, PhD, Kyowa Hakko Kirin California Inc.April 11, 2013Speakers: Yukimasa Shiotsu Run Time: 18 minutes Yukimasa Shiotsu, PhD, is Director of Translational Oncology for Kyowa Hakko Kirin California. He has more than 15 years experience in oncology... |
Cancer Stem Cell Research: From Bench, to Bedside and BackCatriona Jamieson, MD, PhD, Moores Cancer CenterApril 11, 2013Speakers: Catriona Jamieson Run Time: 26 minutes Catriona Jamieson, MD, PhD is Associate Professor of Medicine in the Division of Hematology-Oncology and Director for Stem Cell Research at Moores... |
Cancer Treatment with NK Cell Lines: An Effective Alternative?Armand Keating, MD, FCRP(C), University of Toronto, Princess Margaret HospitalApril 11, 2013Speakers: Armand Keating Run Time: 33 minutes Armand Keating, MD, FCRP(C), is Professor of Medicine, Director , Division of Hematology, Epstein Chair in Cell Therapy and Transplantation and a... |
Carfilzomib: Investigation in Small Cell Lung Cancer (SCLC)Paula O'Connor, MD, Onyx PharmaceuticalsApril 11, 2013Speakers: Paula O'Connor Run Time: 10 minutes Paula O'Connor, MD, is a board eligible hematologist oncologist with 10 ears of industry experience. She serves as Senior Medical Director at Onyx... |
Next Generation Sequencing in the Oncology Clinic: The Foundation Medicine ExperienceGary Palmer, MD, JD, Foundation Medicine Inc.April 11, 2013Speakers: Gary Palmer Run Time: 15 minutes Gary Palmer, MD, JD, is a medical oncologist with a career spanning three decades in oncology, initially as a clinician in both the academic and... |
Center for Personalized Cancer Therapy: Making Individualized Therapy a RealityRazelle Kurzrock, MD, Moores Cancer CenterApril 11, 2013Speakers: Razelle Kurzrock Run Time: 21 minutes Razelle Kurzrock, MD, is Senior Deputy Center Director for Clinical Science at the UC San Diego Moores Cancer Center. She oversees the clinical... |
Genomics and Engineering LifeJ. Craig Venter, PhD, J. Craig Venter Institute (JCVI), Synthetic Genomics, Inc. (SGI)April 11, 2013Speakers: J. Craig Venter Run Time: 35 minutes J. Craig Venter is the Founder, Chairman and President of the J. Craig Venter Institute (JCVI) a not-for-profit research and support organization... |